BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37466867)

  • 21. Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer.
    Kita R; Miyata H; Sugimura K; Tanaka K; Makino T; Yamashita K; Yamasaki M; Motoori M; Shiraishi O; Kimura Y; Yasuda T; Yano M; Doki Y
    Clin Nutr; 2021 Jun; 40(6):4380-4385. PubMed ID: 33526287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
    Depypere L; Moons J; Lerut T; De Hertogh G; Peters C; Sagaert X; Coosemans W; Van Veer H; Nafteux P
    Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal muscle status and survival among patients with advanced biliary tract cancer.
    Takaoka S; Hamada T; Takahara N; Saito K; Endo G; Hakuta R; Ishida K; Ishigaki K; Kanai S; Kurihara K; Oyama H; Saito T; Sato T; Suzuki T; Suzuki Y; Tange S; Tokito Y; Tateishi R; Nakai Y; Fujishiro M
    Int J Clin Oncol; 2024 Mar; 29(3):297-308. PubMed ID: 38319509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body composition predictors of mortality on computed tomography in patients with spinal metastases undergoing surgical treatment.
    Bongers MER; Groot OQ; Buckless CG; Kapoor ND; Twining PK; Schwab JH; Torriani M; Bredella MA
    Spine J; 2022 Apr; 22(4):595-604. PubMed ID: 34699994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer.
    Srpcic M; Jordan T; Popuri K; Sok M
    Radiol Oncol; 2020 Mar; 54(2):237-246. PubMed ID: 32229679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sarcopenia impacts perioperative and survival outcomes after esophagectomy for cancer: a multicenter study.
    Park JS; Colby M; Seyfi D; Leibman S; Laurence JM; Smith G; Falk GL; Sandroussi C
    J Gastrointest Surg; 2024 Jun; 28(6):805-812. PubMed ID: 38548573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcopenia as a Predictor of Prognosis in Early Stage Ovarian Cancer.
    Chae SH; Lee C; Yoon SH; Shim SH; Lee SJ; Kim SN; Chung S; Lee JY
    J Korean Med Sci; 2021 Jan; 36(1):e2. PubMed ID: 33398939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer.
    Sheetz KH; Zhao L; Holcombe SA; Wang SC; Reddy RM; Lin J; Orringer MB; Chang AC
    Dis Esophagus; 2013; 26(7):716-22. PubMed ID: 23350746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.
    Kamitani N; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
    Surg Today; 2019 Dec; 49(12):1022-1028. PubMed ID: 31309328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Retrospective Study of 52 Patients With Primary Small Cell Carcinoma of the Esophagus Treated With Radical Surgery.
    Fan N; Wang Z; Huang Y; Tan Z; Yang H; Lin P
    Cancer Control; 2021; 28():10732748211027147. PubMed ID: 34155924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
    Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
    Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer.
    Mayanagi S; Tsubosa Y; Omae K; Niihara M; Uchida T; Tsushima T; Yokota T; Sato H; Naito T; Yasui H
    Ann Surg Oncol; 2017 Nov; 24(12):3741-3747. PubMed ID: 28861809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
    Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer.
    Paireder M; Asari R; Kristo I; Rieder E; Tamandl D; Ba-Ssalamah A; Schoppmann SF
    Eur J Surg Oncol; 2017 Feb; 43(2):478-484. PubMed ID: 28024944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
    Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
    Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actual Sarcopenia Reflects Poor Prognosis in Patients with Esophageal Cancer.
    Watanabe A; Oshikiri T; Sawada R; Harada H; Urakawa N; Goto H; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Makiura D; Kakeji Y
    Ann Surg Oncol; 2022 Jun; 29(6):3670-3681. PubMed ID: 35169977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis.
    Fang P; Zhou J; Xiao X; Yang Y; Luan S; Liang Z; Li X; Zhang H; Shang Q; Zeng X; Yuan Y
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):3-16. PubMed ID: 36415154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.
    Akce M; Liu Y; Zakka K; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT; Bilen MA; El-Rayes BF
    Am J Clin Oncol; 2021 Feb; 44(2):74-81. PubMed ID: 33350681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantity and Quality of Skeletal Muscle as an Important Predictor of Clinical Outcomes in Patients with Esophageal Cancer Undergoing Esophagectomy after Neoadjuvant Chemotherapy.
    Ishida T; Makino T; Yamasaki M; Yamashita K; Tanaka K; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Eguchi H; Doki Y
    Ann Surg Oncol; 2021 Nov; 28(12):7185-7195. PubMed ID: 33876359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High visceral fat attenuation and long-term mortality in a health check-up population.
    Lee JH; Choi SH; Jung KJ; Goo JM; Yoon SH
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1495-1507. PubMed ID: 37016984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.